Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-032073

EVP & Chief R & QA Officer sold 25,860 shares at $50.03 ($1,293,776)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Clark Mitchall G. EVP & Chief R & QA Officer 2018-05-18 Sale −25,860 $50.03 $1,293,776 107,972 D
Open-market sales · 25,860 sh · avg $50.03 · $1,293,776
Loading xslF345X03/doc4.xml…